Cork’s Pfizer plant, based in Ringaskiddy, will be used to manufacture the new Covid-19 pill that the pharmaceutical company has created.
The drug has just recently completed its first trial which was stopped early after it had shown an 89% efficacy rate in regards to reducing hospitalisation and death.
The pill, which is also administered with an antiviral called ritonavir will have its interim trial results submitted to the Food and Drug Administration (FDA).
According to Pfizer chief Albert Bourla, the filing is expected to be submitted before November 25th.
The Cork plant will begin manufacturing the drug before being sent off to other plants in Europe to be finished.
The plant has already begun manufacturing the drug so that supplies are available upon the pill’s approval being granted.